Filing Details
- Accession Number:
- 0001213900-21-016995
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-22 17:00:08
- Reporting Period:
- 2021-03-19
- Accepted Time:
- 2021-03-22 17:00:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1000683 | Blonder Tongue Laboratories Inc | BDR | Radio & Tv Broadcasting & Communications Equipment (3663) | 521611421 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1054061 | /Nj/ H James Williams | C/O Blonder Tongue Laboratories, Inc. One Jake Brown Road Old Bridge NJ 08857 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Disposition | 2021-03-19 | 35,009 | $1.51 | 398,347 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock Par Value $0.001 | Stock Option (right to buy) | Acquisiton | 2021-03-19 | 20,000 | $0.00 | 20,000 | $1.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,000 | 2031-03-19 | No | 4 | A | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.50 to $1.53. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- The stock option was granted under the 2016 Director Equity Incentive Plan.
- The exercise price equals the fair market value (equal to the closing selling price as reported on the NYSE American) of the common stock on the grant date.
- The stock option vests on the first anniversary of the grant date.